Filing Details
- Accession Number:
- 0001628280-24-050113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-05 17:05:14
- Reporting Period:
- 2024-11-01
- Accepted Time:
- 2024-12-05 17:05:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 1600 West End Avenue Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-01 | 38 | $1.15 | 29,055 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-04 | 25 | $1.17 | 29,080 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-05 | 38 | $1.20 | 29,118 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-06 | 38 | $1.20 | 29,156 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-07 | 38 | $1.17 | 29,194 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-08 | 38 | $1.18 | 29,232 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-11 | 38 | $1.20 | 29,270 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-12 | 38 | $1.20 | 29,308 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-13 | 38 | $1.20 | 29,346 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-14 | 38 | $1.19 | 29,384 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-15 | 38 | $1.17 | 29,422 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-18 | 38 | $1.18 | 29,460 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-19 | 38 | $1.15 | 29,498 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-20 | 43 | $1.13 | 29,541 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-21 | 43 | $1.09 | 29,584 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-22 | 16 | $1.07 | 29,600 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-25 | 16 | $1.09 | 29,616 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-26 | 16 | $1.09 | 29,632 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-27 | 16 | $1.15 | 29,648 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-11-29 | 16 | $1.32 | 29,664 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.